University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Genvoya

Genvoya (Elvitegravir + Cobicistat + tenofovir alafenamide + Emtriva)

Type of Drug: Fixed-Dose Combination
Fixed-dose combinations combine the most commonly prescribed doses of 2 or more medications into a single pill.

Approved adult dosing

Elvitegravir 150 mg + Cobicistat 150 mg + tenofovir alafenamide 10 mg + Emtriva 200 mg in a single tablet

  • one tablet

    Genvoya

    Genvoya

Note: Stribild

Notes on taking this medication

  • Take with food (do not take without food)
  • Genvoya interacts with some over the counter antacid medicines; check with your medical provider before using these medicines
  • Genvoya can interact with other drugs; consult your medical provider
  • Persons with kidney problems may need an adjustment to their doses of the component drugs, so may not be able to take this combination pill

Side effects

    Stribild has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

Same side effects as

Elvitegravir

  • Diarrhea, headache

Cobicistat

  • Nausea, diarrhea
  • Headache
  • Fatigue
  • Elevation in blood creatinine levels (this is used to assess kidney function; your provider will monitor creatinine)

Tenofovir alafenamide (TAF)

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Possible kidney impairment
  • TAF is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

Emtriva

  • Skin discoloration (particularly in dark-skinned people)
  • Headache; diarrhea; nausea
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Contents
Scroll over drug name to see other names for the drug.